Have a personal or library account? Click to login
The Growing Trend of Prescribing Antipsychotics for Young People in Finland, 2000 to 2010 Cover

The Growing Trend of Prescribing Antipsychotics for Young People in Finland, 2000 to 2010

Open Access
|Nov 2015

References

  1. Verdoux H, Tournier M, Bégaud B. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand 2010;121:4-10.
  2. Alessi-Severini S, Biscontri RG, Collins DM, Sareen J, Enns MW. Ten years of antipsychotic prescribing to children: a Canadian population-based study. Can J Psychiatry 2012:57:52-58.
  3. Rani F, Murtay ML, Byrne PJ, Wong ICK. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 2008:123;1002-9.
  4. Carlson GA. The dramatic rise in neuroleptic use in children: why do we do it and what does it buy us? Theories from inpatient data 1988-2010. J Child Adolesc Psychopharmacol 2013;23:144-7.
  5. Olfson M, Blanco C, Liu SM, Wang S, Correll CU. National trends in the office-based treatment of children, adolescents and adults with antipsychotics. Arch Gen Psychiatry 2012:69:1247-1256.
  6. Penfold RB, Stewart C, Hunkeler EM, et al. Use of antipsychotic medications in pediatric populations: what do the data say? Curr Psychiatry Rep 2013;15:426. doi:10.1007/s11920-013-0426-8.
  7. Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006;63:679-685.
  8. Correll CU. Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients. Internat Rev Psychiatr 2008:20:195-201.
  9. Walter G, DeLaroche A, Soh N, et al. Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Austr Psychiatr 2008;16:253-262.
  10. Correll CU. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry 2008;69:26-36.
  11. WHO collaborating centre for drug statistics methodology. Available from: http://www.whocc.no/atc_ddd_index/[Accessed 18 March 2011]
  12. Koelch M, Prestel A, Singer H, et al. Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns. J Child Adolesc Psychopharmacol 2009;19:765-770.
  13. Talka A-K, Kumpulainen K. Psychotropic medication use in children in urgent psychiatric inpatient care. Suom Lääkäril 2015;70:33-38 [In Finnish].
  14. Zito JM, Derivan AT, Kratochvil CJ, Safer DJ, Fegert JM, Greenhill LL. Off-label psychophamacologic prescribing for children: history supports close clinical monitoring. Child Adolesc Psychiatry Ment Health 2008;2:24.
  15. Harrison JN, Cluxton-Keller F, Gross D. Prescribing antipsychotics in children: proceed with caution. J Pediatr Health Care 2012;26:139-145.
  16. Vitiello B, Correll C, van Zwieten-Boot B, Zuddas A, Parellada M, Arango C. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Eur Neuropsychoparmacol 2009;19:629-635.
Language: English
Page range: 31 - 35
Published on: Nov 30, 2015
Published by: Psychiatric Research Unit
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2015 Kirsi-Maria Haapasalo-Pesu, Max Karukivi, Simo Saarijärvi, published by Psychiatric Research Unit
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.